CSL and the Australian Biomedical Research Sector: Past, Present and Future

Venue: Atrium and Auditorium, BIO 21

Presenters: Dr Andrew Nash

Dr Andrew Nash will outline the breadth and success of CSL’s engagement with the sector as well as discuss the importance of nurturing and supporting Australia’s next generation of scientific leaders. From its origins as a government funded organisation established 100 years ago CSL has transformed into a leading global biotherapeutics company developing, manufacturing and selling a range of life saving medicines. Much of CSL’s past success can be attributed to the quality of Australian biomedical research and continued collaboration with this sector will be key to CSL’s future growth.

Dr Andrew Nash is Senior Vice President for Research at CSL Limited, as well as an Honorary Associate Professor at the Bio21 Institute at the University of Melbourne.

from
https://events.unimelb.edu.au/events/6846-csl-and-the-australian-biomedical-research-sector-past-present-and